Covid 19
SK Bioscience invests $85M on a 7% share in the vaccine manufacturer, Novavax, to keep it afloat
SG Tylor
Following its setback during the pandemic phase of COVID-19 with a delayed vaccine, Novavax is now aiming for recovery in ...
Twitter and BioNTech under fire for evading COVID-19 vaccine questions
SG Tylor
The regulatory organization overseeing the German communications sector has accused BioNTech of attempting to evade a public discussion regarding vaccine ...
As COVID revenues fall short of expectations, once-flying Pfizer considers cost-cutting measures
SG Tylor
As the revenues from COVID-19 products fluctuate, mostly experiencing a decline, Pfizer is now considering implementing cost-cutting measures. During a ...
